Judy S. LaKind, PhD

PhD - The Johns Hopkins University; Geography and Environmental Engineering; 1988
MS - The University of Wisconsin, Madison; Geology; 1984
BA - The Johns Hopkins University; Earth and Planetary Sciences; 1982

Judy LaKind, Ph.D., President of LaKind Associates, LLC, and Adjunct Associate Professor, Department of Epidemiology and Public Health, University of Maryland School of Medicine is a health and environmental scientist with expertise in exposure science, assessment of human health risks, biomonitoring, scientific and technical analysis for regulatory support, and systematic reviews. Dr. LaKind is also the past President of the International Society of Exposure Science.

Dr. LaKind has spoken and published extensively on exposure- and risk-related issues, including children’s exposures to environmental chemicals, the implications of uncertainty in the risk assessment process, weighing potential risks and benefits related to chemical use, the presence of environmental chemicals in human milk, and time-dependence and distributional analysis of exposure.

She serves on the editorial boards of the Journal of Toxicology and Environmental Health and Environment International and is past Associate Editor for the Journal of Exposure Science and Environmental Epidemiology.

exposure science, biomonitoring, systematic review, risk assessment

LaKind JS, Burns CJ, Pottenger LH, Naiman DQ, Goodman JE, Marchitti SA. 2021. Does ozone inhalation cause adverse metabolic effects in humans? A systematic review. Critical Reviews in Toxicology In press.

Verner M-A, Salame H, Housand C, Birnbaum LS, Bouchard M, Chevrier J, Aylward L, Naiman DQ, LaKind JS. 2020. How many urine samples are needed to accurately assess exposure to nonpersistent chemicals? The Biomarker Reliability Assessment Tool (BRAT) for scientists, research sponsors and risk managers. International Journal of Environmental Research and Public Health 17, 9102; doi:10.3390/ijerph17239102.

Brozek J, Canelo C, Akl E, Bowen J, Bucher J, Chiu W, Cronin M, Djulbegovic B, Falavigna M, Guyatt G, Gordon A, Hilton Boon M, Hutubessy R, Joore M, Katikireddi S, LaKind J, Langendam M, Manja V, Magnuson K, Mathioudakis A, Meerpohl J, Mertz D, Mezencev R, Morgan R, Morgano GP, Mustafa R, Naidoo B, O'Flaherty M, Patlewicz G, Riva J, Posso M, Ringborg A, Rooney A, Schlosser P, Schwartz L, Shemilt I, Tarride J-E, Thayer K, Tsaioun K, Vale L, Wambaugh J, Wignall JA, Williams AR, Xie F, Zhang Y, Schünemann H. 2020. GRADE Guidelines 30: The GRADE Approach to Assessing the Certainty of Evidence from Models – an Overview in the Context of Health Decision-making. Journal of Clinical Epidemiology S0895- 4356(20)31103-3.

Goodman M, Li J, Flanders WD, Mahood D, Anthony LG, Zhang Q, LaKind JS. 2020. Epidemiology of PCBs and neurodevelopment: Systematic assessment of multiplicity and completeness of reporting. Global Epidemiology 2:100040.

LaKind JS, Naiman J, Burns CJ. Translation of exposure and epidemiology for risk assessment: A shifting paradigm. 2020. International Journal of Environmental Research and Public Health 17(12):4220; https://doi.org/10.3390/ijerph17124220.

LaKind JS, Burns CJ, Erickson H, Graham SE, Jenkins S, Johnson GT. 2020. Bridging the epidemiology risk assessment gap: An NO2 case study of the Matrix. Global Epidemiology 2:100017.